Higher app engagement was associated with greater weight loss at 16 weeks
Tesamorelin: The One That Targets Visceral Fat Tesamorelin is a growth hormone-releasing hormone analog that was originally approved by the FDA to reduce excess belly fat in patients with HIV-associated lipodystrophy
The microdosing tirzepatide chart that most providers reference breaks this into weekly increments
GHK-Cu with GLP-1 medications
Medication Active Compound Monthly Cost (No Insurance) With Cash-Pay Programs Ozempic Semaglutide $935$1,100 $199$499/mo Wegovy Semaglutide $1,350$1,639 $199$349/mo Mounjaro Tirzepatide $1,000$1,200 ~$1,000/mo Zepbound Tirzepatide $1,060$1,200 $349/mo (self-pay) Rybelsus Semaglutide (oral) $935$1,000 Varies The cash-pay programs from Novo Nordisk (Ozempic/Wegovy) and Eli Lilly (Zepbound) have changed the landscape
Psychological and Behavioral Considerations Weight loss medications work best when combined with attention to the psychological and behavioral aspects of eating